Latest Breaking News On - Alimera sciences - Page 6 : comparemela.com

Alimera Sciences (NASDAQ:ALIM) Coverage Initiated by Analysts at StockNews com

StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research note released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Alimera Sciences Price Performance Shares of NASDAQ ALIM opened at $3.90 on Friday. The business has a fifty day moving average price of $3.56 and […]

United statesAlimera sciences incAlimera sciences price performanceInstitutional investors weigh in on alimera sciencesSusquehanna international groupNews ratings for alimera sciences dailyAlimera sciencesCapital managementWorth venture partnersStonepine capital managementFree reportGet free reportCapital investment managementVenture partnersOperating costAlimera sciences daily

Alimera Sciences completes patient enrollment for phase 4 Yutiq Synchronicity study

Alimera Sciences completes patient enrollment for phase 4 Yutiq Synchronicity study
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Heather bieleRick eiswirthAlimera sciences

Alimera Sciences (NASDAQ:ALIM) Earns Hold Rating from Analysts at StockNews com

StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a report published on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Alimera Sciences Price Performance Shares of NASDAQ:ALIM opened at $4.08 on Friday. Alimera Sciences has a 52 week low of $1.30 and a 52 week […]

United statesCapital managementVanguard group incTower research capitalAlimera sciences incNews ratings for alimera sciences dailyAlimera sciences price performanceStonepine capital managementAlimera sciencesWorth venture partnersInstitutional trading of alimera sciencesFree reportGet free reportVenture partnersResearch capitalOperating cost

StockNews com Initiates Coverage on Alimera Sciences (NASDAQ:ALIM)

StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a report published on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. Alimera Sciences Price Performance Shares of NASDAQ:ALIM opened at $3.81 on Friday. The company’s fifty day moving average price is $3.44 and its 200 day moving […]

United statesTower research capitalVanguard group incNews ratings for alimera sciences dailyAlimera sciences price performanceStonepine capital managementAlimera sciences incCapital managementAlimera sciencesWorth venture partnersFree reportGet free reportVenture partnersResearch capitalOperating costAlimera sciences daily

Analysts New Coverage for December 23rd (AGLE, AINC, ALIM, APDN, BKCC, BKSC, BLIN, BYFC, CASI, CBFV)

Analysts’ new coverage for Saturday, December 23rd: StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). StockNews.com issued a sell rating on the stock. StockNews.com initiated coverage on shares of Ashford (NYSEAMERICAN:AINC). They issued a buy rating on the stock. StockNews.com began coverage on shares of Alimera Sciences (NASDAQ:ALIM). StockNews.com issued a hold rating on […]

United statesSouth carolinaAeglea biotherapeutics incNews ratings for aeglea biotherapeutics inc dailyCodorus valley bancorpCb financial servicesCreative media community trust coPieris pharmaceuticalsAlimera sciencesComputer task groupBlackrock capital investmentBridgeline digitalBroadway financialCreative mediaCommunity trustDesktop metal